Search Results - clinical+and+disease+specializations+%3e+ophthalmology+%3e+corneal+neovascularization

2 Results

Sort By:

Dual-Target Vascular Endothelial Growth Factor (VEGF) Therapy for Treating Ocular Neovascularization

Value Proposition· Comprehensive Targeting: Engineered antagonist proteins combine elements of both VEGF receptor (VEGFR)-1 and VEGFR-2 to target all human VEGF ligands and sequester 2 ligand homodimers simultaneously.· Superior Inhibition: Comprehensive ligand blockade inhibits neovascularization more effectively than existing VEGF-A only...

Published: 4/24/2026 | Inventor(s): Jamie Spangler, Raquel Formica, Peter Campochiaro, Paul Sargunas

Keywords(s):

Non-surgical treatment for corneal blindness

Value Proposition· Non-surgical, non-invasive treatment for loss of vision caused by corneal damage.· Cost effective to manufacture· Easy application· Regenerates existing cornea structure to restore vision.Unmet NeedThe only curative option for many cases of corneal blindness remains surgical corneal transplantation, a resource‑intensive...

Published: 4/24/2026 | Inventor(s): Kannan Rangaramanujam, Samuel Yiu, Minjie Chen, Siva Pramodh Kambhampati, Hui Lin

Keywords(s):

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Ophthalmology, Clinical and Disease Specializations > Ophthalmology > Corneal Dystrophy, Clinical and Disease Specializations > Ophthalmology > Corneal Neovascularization, Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers